Cardiac, renal, and metabolic effects of sodium-glucose co-transporter 2 inhibitors: a position paper from the European Society of Cardiology ad-hoc task force on sodium-glucose co-transporter 2 inhibitors. (2021)
Attributed to:
Vascular disease meta analyses
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1002/ejhf.2286
PubMed Identifier: 34184823
Publication URI: http://europepmc.org/abstract/MED/34184823
Type: Journal Article/Review
Volume: 23
Parent Publication: European journal of heart failure
Issue: 8
ISSN: 1388-9842